Drugs Limiting Excess Mucus Could Save Lives (2 of 2) (AUDIO)
Caption
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions – excess mucus production. Now, researchers at Washington University School of Medicine in St. Louis have described the molecular pathway responsible for excess mucus in airway cells and have used that information to design a series of new drugs that inhibit that pathway.
Credit
Washington University School of Medicine in St. Louis
Usage Restrictions
None
License
Licensed content